Found 7 articles for: "Basal Cell Carcinoma"
Cryosurgery and 5-Fluorouracil Combination Therapy for Treatment of Bowen's Disease and Superficial Basal Cell Carcinoma
December 2023 | Volume 22 | Issue 12 | Original Article | 1166 | Copyright © December 2023
Background: Non-melanoma skin cancer (NMSC), which includes both Bowen's disease (BD) and superficial basal cell carcinoma (sBCC), is the most commonly diagnosed cancer in Canada...
Read MoreNon-Invasive Treatment of Basal Cell Carcinoma: Photodynamic Therapy Following Curettage
May 2023 | Volume 22 | Issue 5 | Original Article | 481 | Copyright © May 2023
Background: To investigate the effectiveness, safety, patient satisfaction, and cosmetic outcome of Methyl Aminolevulinate-Photodynamic Therapy (MAL-PDT) following curettage in o...
Read MorePigmented Basal Cell Carcinoma: An Argument for Sub-Classification
February 2023 | Volume 22 | Issue 2 | Features | 217 | Copyright © February 2023
Basal cell carcinoma (BCC) has several subclassifications, including pigmented basal cell carcinoma. In our clinical experience, we have found that pigmented basal cell carcinoma itself has multiple s...
Read MoreGiant Basal Cell Carcinoma of the Axilla: 8-year Follow-up of a Case Treated with Excision, Vismodegib, and Radiotherapy
May 2022 | Volume 21 | Issue 5 | Case Reports | 531 | Copyright © May 2022
Axillary giant basal cell carcinoma is extremely rare and remains challenging for physicians. The few reported cases have a relatively short-term follow-up, and none were treated with an oral hedgehog...
Read MoreCharacteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis
August 2021 | Volume 20 | Issue 8 | Original Article | 874 | Copyright © August 2021
Background: The prognosis and treatment of basal cell carcinoma (BCC) are largely dependent on tumor subtype, which is typically determined by punch or shave biopsy. Data regarding co...
Read MoreBasal Cell Carcinoma Gene Mutations Differ Between Asian, Hispanic, and Caucasian Patients: A Pilot Study
May 2021 | Volume 20 | Issue 5 | Original Article | 504 | Copyright © May 2021
Background: Basal cell carcinoma (BCC) is the most common malignancy worldwide. While most BCCs are treated surgically, adv...
Read MoreCharacteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis
March 2021 | Volume 20 | Issue 3 | Original Article | 283 | Copyright © March 2021
Background: The prognosis and treatment of basal cell carcinoma (BCC) are largely dependent on tumor subtype, which is typically determined by punch or shave biopsy. Data regarding co...
Read More
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.